In North American centers (UCSF, UCLA), the c-index of TRIUMPH was 0.72 (95% CI: 0.57–0.87), slightly lower than HALT-HCC (c-index: 0.74, 95% CI: 0.58–0.91) but still higher than the MORAL and AFP models. This evidence concerns the gene AFP and hepatocellular carcinoma.